- Home
- ASPI vs THW Comparison
ASPI vs THW Comparison
Compare ASPI & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASPI | THW |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 639.3M | 513.9M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ASPI | THW |
|---|---|---|
| Price | $5.34 | $12.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 135.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,144,226.00 | N/A |
| Revenue This Year | $108.31 | N/A |
| Revenue Next Year | $403.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 857.04 | N/A |
| 52 Week Low | $3.92 | $9.80 |
| 52 Week High | $14.49 | $13.19 |
Technical Indicators
Market Signals| Indicator | ASPI | THW |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 45.95 |
| Support Level | $5.18 | $11.83 |
| Resistance Level | $5.95 | $13.00 |
| Average True Range (ATR) | 0.53 | 0.22 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 26.13 | 43.96 |
Price Performance
Historical ComparisonAbout ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.